Florida's $250M development cache threatened

Florida has come up with a cache of $250 million to further prod the growth of its biotech sector, but county officials say they will have trouble coming up with the matching funds needed to get access to the money. Florida has won wide acclaim for drawing in some of the world's top research institutes, and now the Max Planck Institute and New York's Rockefeller University are rumored to be interested in expanding in the sunshine state. Another big project in the works: the IBM-Scripps Florida program for influenza. If Florida can pull off any of these, it will gain another leg up on the 50-state competition for biotech projects. FierceBiotech picked Florida as one of the top five regions attracting biotech business in 2007.

- read the Palm Beach Post report

Related Articles:
Can Florida woo biotechs? Report
Florida gets an honorable mention, with a warning. Report
Scripps Florida sees first biotech spin-off take root. Report

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.